Low genetic diversity may be an Achilles heel of SARS-CoV-2

Proc Natl Acad Sci U S A. 2020 Oct 6;117(40):24614-24616. doi: 10.1073/pnas.2017726117. Epub 2020 Sep 21.

Authors

Jason W Rausch¹, Adam A Capoferri^{1

2}, Mary Grace Katusiime¹, Sean C Patro¹, Mary F Kearney³

Affiliations

¹ HIV Dynamics & Replication Program, Center for Cancer Research, National Cancer Institute at Frederick, Frederick, MD 21702.
² Microbiology and Immunology Department, Georgetown University, Washington, DC 20007.
³ HIV Dynamics & Replication Program, Center for Cancer Research, National Cancer Institute at Frederick, Frederick, MD 21702; kearneym@mail.nih.gov.

No abstract available

Publication types

Comment

MeSH terms

Betacoronavirus
COVID-19
COVID-19 Vaccines
Coronavirus Infections* / prevention & control
Genetic Variation
Humans
Pandemics*
Pneumonia, Viral*
SARS-CoV-2
Severe Acute Respiratory Syndrome*
Viral Vaccines

Substances

COVID-19 Vaccines
Viral Vaccines